These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 33060681)
1. Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy. Ando S; Suzuki S; Okubo S; Ohuchi K; Takahashi K; Nakamura S; Shimazawa M; Fuji K; Hara H Sci Rep; 2020 Oct; 10(1):17472. PubMed ID: 33060681 [TBL] [Abstract][Full Text] [Related]
2. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells. Pagliarini V; Guerra M; Di Rosa V; Compagnucci C; Sette C J Neurochem; 2020 Apr; 153(2):264-275. PubMed ID: 31811660 [TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. Williams JH; Schray RC; Patterson CA; Ayitey SO; Tallent MK; Lutz GJ J Neurosci; 2009 Jun; 29(24):7633-8. PubMed ID: 19535574 [TBL] [Abstract][Full Text] [Related]
4. A SMN2 Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model. Son YS; Choi K; Lee H; Kwon O; Jung KB; Cho S; Baek J; Son B; Kang SM; Kang M; Yoon J; Shen H; Lee S; Oh JH; Lee HA; Lee MO; Cho HS; Jung CR; Kim J; Cho S; Son MY Stem Cells Dev; 2019 Apr; 28(7):438-453. PubMed ID: 30667343 [TBL] [Abstract][Full Text] [Related]
5. [Risdiplam for the treatment of spinal muscular atrophy]. Vlodavets DV Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):45-57. PubMed ID: 38465810 [TBL] [Abstract][Full Text] [Related]
6. The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy. Kletzl H; Marquet A; Günther A; Tang W; Heuberger J; Groeneveld GJ; Birkhoff W; Mercuri E; Lochmüller H; Wood C; Fischer D; Gerlach I; Heinig K; Bugawan T; Dziadek S; Kinch R; Czech C; Khwaja O Neuromuscul Disord; 2019 Jan; 29(1):21-29. PubMed ID: 30553700 [TBL] [Abstract][Full Text] [Related]
7. RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotides. Torroba B; Macabuag N; Haisma EM; O'Neill A; Herva ME; Redis RS; Templin MV; Black LE; Fischer DF Expert Opin Drug Discov; 2023 Feb; 18(2):181-192. PubMed ID: 36408582 [TBL] [Abstract][Full Text] [Related]
9. Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs. Poirier A; Weetall M; Heinig K; Bucheli F; Schoenlein K; Alsenz J; Bassett S; Ullah M; Senn C; Ratni H; Naryshkin N; Paushkin S; Mueller L Pharmacol Res Perspect; 2018 Dec; 6(6):e00447. PubMed ID: 30519476 [TBL] [Abstract][Full Text] [Related]
10. Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing modifier for spinal muscular atrophy (SMA). Markati T; Fisher G; Ramdas S; Servais L Expert Opin Investig Drugs; 2022 May; 31(5):451-461. PubMed ID: 35316106 [TBL] [Abstract][Full Text] [Related]
11. Effects of Inhibitors of SLC9A-Type Sodium-Proton Exchangers on Kanda S; Moulton E; Butchbach MER Mol Pharmacol; 2022 Aug; 102(2):92-105. PubMed ID: 35667685 [TBL] [Abstract][Full Text] [Related]
12. A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes. Singh NN; Seo J; Rahn SJ; Singh RN PLoS One; 2012; 7(11):e49595. PubMed ID: 23185376 [TBL] [Abstract][Full Text] [Related]
13. Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of Toosaranont J; Ruschadaariyachat S; Mujchariyakul W; Arora JK; Charoensawan V; Suktitipat B; Palmer TN; Fletcher S; Wilton SD; Mitrpant C Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409296 [TBL] [Abstract][Full Text] [Related]
14. Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA). Ratni H; Ebeling M; Baird J; Bendels S; Bylund J; Chen KS; Denk N; Feng Z; Green L; Guerard M; Jablonski P; Jacobsen B; Khwaja O; Kletzl H; Ko CP; Kustermann S; Marquet A; Metzger F; Mueller B; Naryshkin NA; Paushkin SV; Pinard E; Poirier A; Reutlinger M; Weetall M; Zeller A; Zhao X; Mueller L J Med Chem; 2018 Aug; 61(15):6501-6517. PubMed ID: 30044619 [TBL] [Abstract][Full Text] [Related]
15. Improvement of spinal muscular atrophy via correction of the SMN2 splicing defect by Brucea javanica (L.) Merr. extract and Bruceine D. Baek J; Jeong H; Ham Y; Jo YH; Choi M; Kang M; Son B; Choi S; Ryu HW; Kim J; Shen H; Sydara K; Lee SW; Kim SY; Han SB; Oh SR; Cho S Phytomedicine; 2019 Dec; 65():153089. PubMed ID: 31563042 [TBL] [Abstract][Full Text] [Related]
16. Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts. Farrelly-Rosch A; Lau CL; Patil N; Turner BJ; Shabanpoor F Neurochem Int; 2017 Sep; 108():213-221. PubMed ID: 28389270 [TBL] [Abstract][Full Text] [Related]
17. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536 [TBL] [Abstract][Full Text] [Related]
18. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [TBL] [Abstract][Full Text] [Related]